​

Coherus BioSciences (CHRS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Coherus BioSciences Revenue Highlights

Latest Revenue (Y)

$257.24M

Latest Revenue (Q)

$70.77M

Main Segment (Y)

Product Revenue

Main Geography (Y)

UNITED STATES

Coherus BioSciences Revenue by Period

Coherus BioSciences Revenue by Year

DateRevenueChange
2023-12-31$257.24M21.89%
2022-12-31$211.04M-35.37%
2021-12-31$326.55M-31.37%
2020-12-31$475.82M33.63%
2019-12-31$356.07M22783.74%
2018-12-31$1.56M-
2017-12-31$1.56M-99.18%
2016-12-31$190.11M532.82%
2015-12-31$30.04M-3.42%
2014-12-31$31.11M1030.72%
2013-12-31$2.75M44.87%
2012-12-31$1.90M-

Coherus BioSciences generated $257.24M in revenue during NA 2023, up 21.89% compared to the previous quarter, and up 16532.39% compared to the same period a year ago.

Coherus BioSciences Revenue by Quarter

DateRevenueChange
2024-09-30$70.77M8.92%
2024-06-30$64.98M-15.68%
2024-03-31$77.06M-15.80%
2023-12-31$91.52M22.74%
2023-09-30$74.57M27.00%
2023-06-30$58.72M81.02%
2023-03-31$32.44M-28.48%
2022-12-31$45.35M-0.16%
2022-09-30$45.42M-24.48%
2022-06-30$60.15M0.06%
2022-03-31$60.12M-18.07%
2021-12-31$73.37M-11.07%
2021-09-30$82.50M-5.86%
2021-06-30$87.64M5.55%
2021-03-31$83.03M-24.80%
2020-12-31$110.42M-2.76%
2020-09-30$113.55M-16.31%
2020-06-30$135.67M16.78%
2020-03-31$116.18M-6.20%
2019-12-31$123.86M10.90%
2019-09-30$111.68M33.86%
2019-06-30$83.43M124.90%
2019-03-31$37.10M100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30--100.00%
2017-06-30$1.40M766.46%
2017-03-31$161.00K-80.92%
2016-12-31$844.00K-99.48%
2016-09-30$162.84M1057.49%
2016-06-30$14.07M13.83%
2016-03-31$12.36M21.19%
2015-12-31$10.20M42.29%
2015-09-30$7.17M4.38%
2015-06-30$6.87M18.18%
2015-03-31$5.81M-10.52%
2014-12-31$6.49M-59.55%
2014-09-30$16.05M223.30%
2014-06-30$4.96M38.07%
2014-03-31$3.60M191.88%
2013-12-31$1.23M143.48%
2013-09-30$506.00K-

Coherus BioSciences generated $70.77M in revenue during Q3 2024, up 8.92% compared to the previous quarter, and up 120.54% compared to the same period a year ago.

Coherus BioSciences Revenue Breakdown

Coherus BioSciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 19
Other$664.00K$282.00K--
Product Revenue$256.58M$210.76M$326.60M-
License And Service----
Product---$356.07M

Coherus BioSciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product Revenue (99.74%), and Other (0.26%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Jun 23Mar 23Mar 22Dec 21Sep 21Jun 21Mar 21
Product and Service, Other$220.00K---------
Product$70.55M$82.50M$87.60M$83.00M------
Product Revenue-$76.74M$165.77M$58.46M$32.35M$60.10M$73.40M---
Other-$320.00K$322.00K$259.00K$83.00K-----

Coherus BioSciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (99.69%), and Product and Service, Other (0.31%).

Coherus BioSciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 19
Non Us-
UNITED STATES$356.07M

Coherus BioSciences's latest annual revenue breakdown by geography, as of Dec 19: UNITED STATES (100.00%).

Coherus BioSciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CHRSCoherus BioSciences$257.24M$70.77M
CTMXCytomX Therapeutics$101.21M$33.43M
SPROSpero Therapeutics$96.73M$13.47M
BOLTBolt Biotherapeutics$7.88M$1.14M
ASMBAssembly Biosciences$7.16M$6.84M
NXTCNextCure--
TILInstil Bio--
ACHLAchilles Therapeutics--
NUVBNuvation Bio-$727.00K

CHRS Revenue FAQ

What is Coherus BioSciences’s yearly revenue?

Coherus BioSciences's yearly revenue for 2023 was $257.24M, representing an increase of 21.89% compared to 2022. The company's yearly revenue for 2022 was $211.04M, representing a decrease of -35.37% compared to 2021. CHRS's yearly revenue for 2021 was $326.55M, representing a decrease of -31.37% compared to 2020.

What is Coherus BioSciences’s quarterly revenue?

Coherus BioSciences's quarterly revenue for Q3 2024 was $70.77M, a 8.92% increase from the previous quarter (Q2 2024), and a -5.09% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $64.98M, a -15.68% decrease from the previous quarter (Q1 2024), and a 10.67% increase year-over-year (Q2 2023). CHRS's quarterly revenue for Q1 2024 was $77.06M, a -15.80% decrease from the previous quarter (Q4 2023), and a 137.58% increase year-over-year (Q1 2023).

What is Coherus BioSciences’s revenue growth rate?

Coherus BioSciences's revenue growth rate for the last 3 years (2021-2023) was -21.22%, and for the last 5 years (2019-2023) was -27.75%.

What are Coherus BioSciences’s revenue streams?

Coherus BioSciences's revenue streams in c 23 are Other, and Product Revenue. Other generated $664K in revenue, accounting 0.26% of the company's total revenue, up 135.46% year-over-year. Product Revenue generated $256.58M in revenue, accounting 99.74% of the company's total revenue, up 21.74% year-over-year.

What is Coherus BioSciences’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Coherus BioSciences was Product Revenue. This segment made a revenue of $256.58M, representing 99.74% of the company's total revenue.